AKT2 Antibody (C-term) Blocking Peptide

Produktübersicht

• Artikelname: AKT2 Antibody (C-term) Blocking Peptide
• Artikelnummer: ABT-BP7029B
• Hersteller Artikelnummer: BP7029b
• Alternativnummer: ABT-BP7029B-500UG
• Hersteller: Abcepta
• Kategorie: Proteine/Peptide
• Alternative Synonym: RAC-beta serine/threonine-protein kinase, Protein kinase Akt-2, Protein kinase B beta, PKB beta, RAC-PK-beta, AKT2

Produktbeschreibung

AKT2 is a protein belonging to a subfamily of serine/threonine kinases containing SH2-like (Src homology 2-like) domains. AKT2 has been shown to be amplified and overexpressed in 2 of 8 ovarian carcinoma cell lines and 2 of 15 primary ovarian tumors. Overexpression of AKT2 contributes to the malignant phenotype of a subset of human ductal pancreatic cancers. AKT2 is a general protein kinase capable of phophorylating several known proteins.

Produkteigenschaften

• NCBI: 208
• UniProt: P31751
• Formulierung: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
• Target-Kategorie: The synthetic peptide sequence used to generate the antibody AP7029b was selected from the C-term region of human AKT2. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.